-
公开(公告)号:EP4452372A1
公开(公告)日:2024-10-30
申请号:EP22840620.3
申请日:2022-12-19
-
公开(公告)号:EP3791910B1
公开(公告)日:2024-10-16
申请号:EP20192698.7
申请日:2018-12-18
发明人: WUTTKE, Gilbert , GRAESSL, Herbert
-
公开(公告)号:EP4382053A2
公开(公告)日:2024-06-12
申请号:EP23214435.2
申请日:2023-12-05
发明人: ROSCA, Inga , BENN, Niall , SLATTERY, David , LONG, Margaret
CPC分类号: A61B17/00491 , A61B2017/0052220130101 , A61B2017/0054420130101 , A61B2017/0053920130101 , A61M11/02 , A61M25/00
摘要: The present embodiments provide systems suitable for delivering a therapeutic agent to a target site. In some embodiments, the system comprises a container for holding the therapeutic agent, a pressure source, and a catheter in fluid communication with the container. In one embodiment, the system further comprises a first inlet tube disposed at least partially within the container, and a second inlet tube disposed at least partially within the container at a location different than the first inlet tube. Pressurized fluid from the pressure source flows into the container via each of the first inlet tube and the second inlet tube. In other embodiments, a plate is disposed with the container, wherein the plate is able to move vertically within the container during delivery of the therapeutic agent.
-
公开(公告)号:EP3914325B1
公开(公告)日:2024-04-24
申请号:EP20704764.8
申请日:2020-01-17
CPC分类号: A61M15/08 , A61M15/0041 , A61M2205/822520130101 , A61M2202/06420130101 , A61M11/02 , A61M15/0036 , A61K9/0043
-
公开(公告)号:EP4309718A3
公开(公告)日:2024-03-27
申请号:EP23213965.9
申请日:2018-07-03
发明人: MACLOUGHLIN, Ronan , PORTER, Shaun , DUFFY, Conor , POWER, John
摘要: A gas therapy system (1) has a flow line (3, 2), a coupler (6) to a gas source, and an aerosol generator (4) for aerosol delivery, and a patient interface such as a nasal interface (2). A controller (10) is configured to modulate gas flow and aerosol delivery in real time. The controller changes gas flow rate and dynamically reduces aerosol delivery during upper gas flow rates such as 60 LPM, and activates aerosol delivery during lower gas flow rates of for example 10 LPM. The control may also include sensors to detect breathing, so that there is a bias towards increased aerosol delivery during inhalation in addition to during lower level gas flow.
-
公开(公告)号:EP4313221A1
公开(公告)日:2024-02-07
申请号:EP22719803.3
申请日:2022-03-23
发明人: MCDAID, Liam , KELLY, Susan , HARKIN, Jim
-
公开(公告)号:EP4223335A3
公开(公告)日:2023-11-08
申请号:EP23164992.2
申请日:2018-05-21
摘要: A dry powder aerosol delivery device and related methods for delivering precise and repeatable dosages to a subject for pulmonary use is disclosed. The dry powder aerosol delivery device includes a housing, a cartridge, and a dry powder dispersion mechanism, and at least one differential pressure sensor. The dry powder delivery device is automatically breath actuated by the user when the differential pressure sensor senses a predetermined pressure change within housing. The dry powder aerosol delivery device is then actuated to generate a plume of particles having an average ejected particle diameter within the respirable size range, e.g., less than about 5-6 µm, so as to target the pulmonary system of the user.
-
8.
-
-
公开(公告)号:EP4218866A1
公开(公告)日:2023-08-02
申请号:EP23164457.6
申请日:2020-06-19
申请人: Nerudia Ltd.
发明人: SAJTOS, Tamas , AUSTIN, Andrew , LOMAS, Pete , LORD, Chris
摘要: An aerosol delivery device comprising: a storage tank defining a storage chamber for storing a liquid aerosol precursor and a porous liquid transfer element for transferring the liquid aerosol precursor from the storage chamber to an aerosolisation chamber in an activated state of the device. It further comprises an air bleed channel configured to allow the bleeding of air into the chamber of the storage tank to replace liquid aerosol precursor as it is transferred by the liquid transfer element in the activated state of the device. A sealing element for seals the air bleed channel in a deactivated state of the device. The device further comprises first and second activation members depending from an inner surface of a terminal element. In a first orientation of the terminal element, the first activation member is longitudinally aligned with the sealing element, and in a second orientation of the terminal element, the second activation member is longitudinally aligned with the sealing element. Also disclosed is an aerosol delivery device having an aerosolisation chamber extending longitudinally into the device from a mouthpiece aperture of the device. The aerosolisation chamber has a transverse cross-sectional area that is uniform along a longitudinal length of the aerosolisation chamber. Also disclosed is an aerosol delivery device having a hinged cap rotatable relative to a mouthpiece of the device so as to be moveable between a sealing configuration and an open configuration.
-
-
-
-
-
-
-
-
-